NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Rasna Therapeutics Inc (OTCQB: RASP)

 
RASP Technical Analysis
2
As on 9th Jun 2023 RASP STOCK Price closed @ 0.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.02 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RASPSTOCK Price

Open 0.03 Change Price %
High 0.03 1 Day 0.02 200.00
Low 0.03 1 Week 0.02 200.00
Close 0.03 1 Month 0.02 200.00
Volume 132 1 Year 0.00 0.00
52 Week High 0.05 | 52 Week Low 0.00
 
OTCQB USA Most Active Stocks
BMIX 0.01 %
MOBQ 0.18 -5.26%
FNMA 0.45 0.00%
ALPP 3.56 -0.80%
ALPP 3.56 -0.80%
SHMP 0.06 0.00%
NWBO 0.73 0.00%
VPLM 0.08 %
NLST 3.72 -8.60%
SRNA 2.78 14.88%
 
OTCQB USA Top Gainers Stocks
EMMLF 0.89 8800.00%
EWLUD 0.45 275.00%
RASP 0.03 200.00%
RASP 0.03 200.00%
SSEBF 0.02 100.00%
NVAAF 0.40 100.00%
PWWBF 0.02 100.00%
HCAND 0.02 100.00%
SIXWF 0.02 100.00%
IPCIF 0.06 100.00%
 
OTCQB USA Top Losers Stocks
LKMNF 0.01 -50.00%
ALDS 0.01 -50.00%
GMGT 0.03 -50.00%
BNKL 0.60 -39.39%
PPCB 0.05 -37.50%
ATAO 0.09 -35.71%
FCIC 0.38 -34.48%
PKTX 0.02 -33.33%
MNTR 0.02 -33.33%
MNTR 0.02 -33.33%
 
 
RASP
Daily Charts
RASP
Intraday Charts
Whats New @
Bazaartrend
RASP
Free Analysis
 
RASP Important Levels Intraday
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
 
RASP Forecast April 2024
4th UP Forecast0.07
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.04
1st DOWN Forecast0.02
2nd DOWN Forecast0.01
3rd DOWN Forecast0
4th DOWN Forecast-0.01
 
RASP Weekly Forecast
4th UP Forecast0.03
3rd UP Forecast0.03
2nd UP Forecast0.03
1st UP Forecast0.03
1st DOWN Forecast0.03
2nd DOWN Forecast0.03
3rd DOWN Forecast0.03
4th DOWN Forecast0.03
 
RASP Forecast2024
4th UP Forecast0.13
3rd UP Forecast0.1
2nd UP Forecast0.08
1st UP Forecast0.06
1st DOWN Forecast0
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.04
4th DOWN Forecast-0.07
 
 
RASP Other Details
Segment EQ
Market Capital 3135314.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RASP Address
RASP
 
RASP Latest News
 
Your Comments and Response on Rasna Therapeutics Inc
 
RASP Business Profile
Rasna Therapeutics, Inc., a leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia. It focuses on developing molecule drug candidates targeting NPM1 and LSD1, which are implicated in the disease progression of leukemia and lymphoma. The company is developing RASP-201 (LSD1), an enzyme that demethylates lysine side chain of histones; and RASP-301, an NPM1 gene that provides instructions for making nucleophosmin protein. Rasna Therapeutics, Inc. was founded in 2013 and is headquartered in New York, New York. Address: 420 Lexington Avenue, New York, NY, United States, 10170
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service